Lifescience Reagent Market - Life science products for the investigation of COVID-19, Market Share Touch US$ 63.5 Billion by the End of 2027

The raising occurrence of infectious diseases, which necessitates early identification, presents an opportunity for biotechnology companies to develop effective reagents for a variety of diagnostic procedures. Furthermore, the introduction of new diagnostic tests and assays is boosting the market share of life science reagents. For example, Roche launched the Ventana HER2 Dual ISH DNA Probe Cocktail assay in April 2019 for detecting the HER2 biomarker in breast and gastric cancer patients to identify their eligibility for trastuzumab, a targeted medication (Herceptin). The new reagent is designed for use in in vitro diagnostic (IVD) applications.

In 2017, the global life science reagent market was worth US$ 33,754.0 million, and it is predicted to grow at a CAGR of 7.3 percent from 2018 to 2026.

Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/2681

The worldwide life science reagent market is predicted to rise due to an increase in new releases:

The worldwide lifescience reagent market is predicted to develop due to an increase in product launches for reagents to aid various sorts of diagnostic testing and research purposes. For example, Dolomite Bio, a developer of single cell technologies, introduced a new scRNA-Seq reagent kit to the Nadia Instrument range in March 2019. The novel scRNA-Seq reagent kit is designed to allow the Nadia Instrument to generate PCR-amplified cDNA libraries, allowing for high-throughput gene expression profiling of diverse cell populations.

Moreover, in October 2016, Beckman Coulter’s lifescience division launched Clearllab LS Lymphoid Screen Reagent. It is CE-marked and 10-colour containing 12 antibody reagent combinations used for leukemia and lymphoma analysis. In addition, Beckman Coulter's lifescience division introduced Clearllab LS Lymphoid Screen Reagent in October 2016. It's CE-marked and comes in a 10-color kit with 12 antibody reagent combinations for leukaemia and lymphoma testing.

The global lifescience reagent market will benefit from increased acquisitions among biotechnology industry players. For example, Anatrace (a StoneCalibre portfolio company) purchased Molecular Dimensions Ltd. in February 2017. Molecular Dimensions Ltd is a supplier of contemporary screens, reagents, and other consumables and instruments for structural biology in the United Kingdom. Anatrace intended to establish a presence in Europe and expand its structural biology product portfolio with this acquisition.

Tailored Information as per niche requirement:

LIMITED TIME OFFER - Hurry Up!

Exclusive offer!!! Purchase the report at a discounted rate!!!

Get Discount For Buyers UPTO 30% OFF On Any Research Report

Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2681

Regional Analysis:

Due to increased initiatives by market players to build their product portfolio in North America countries, North America is predicted to have lucrative growth in the global lifescience reagent market. Grifols, for example, acquired FDA licencing clearance in May 2018 to sell a spectrum of antisera reagents developed for routine and difficult immunohematology testing in the United States.

In addition, in 2016, LabX Media Group, Inc. purchased 1DegreeBio Inc. (www.1degreebio.com), a lifesciences antibody and reagent search engine. LabX Media Group added 1DegreeBio Inc. to its stable established brands with this acquisition. www.1degreebio.com is a database of lifescience reagents and kits that contains quality validation data, citation history, antibody reviews, and community ratings.

Due to the presence of prominent players in this region, Asia Pacific is likely to drive the global lifescience reagent market growth. For example, in December 2015, Sekisui Chemical, a Japanese business, purchased Eidia, a subsidiary of Eisai, which develops and markets reagents, particularly diagnostic reagents, for cancer and rheumatism treatment. Eisai was a chemical equipment, clinical diagnostic reagents, clinical analyzers, and laboratory reagents manufacturer, importer, and marketer. For US$ 18 million, Sekisui bought the Eidia from Eisai.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/lifescience-reagent-market-to-surpass-us-635-billion-by-2026-1418

Because of the increasing number of approvals from the European Union for diagnostic reagents and assays, Europe is likely to see significant growth in lifescience reagents. HTG Molecular Diagnostics, Inc., for example, gained CE certification in the European Union in March 2017 for their HTG EdgeSeq ALKPlus Assay EU. Instruments, reagents, and services for molecular profiling applications are provided by the company. The HTG EdgeSeq ALKPlus Assay EU measures and analyses mRNA ALK gene rearrangements in formalin-fixed, paraffin-embedded lung tumor specimens from patients previously diagnosed with non-small cell lung cancer (NSCLC).

Table of Contents

1. Research Objective and Assumption
• Research Objectives
• Assumptions
• Abbreviations
2. Market Overview
• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snippet, By Product Type
• Market Snippet, By End User
• Market Snippet, By Region
• Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Technology Advancements
• Historical Overview
• Merger and Acquisition
• Regulatory Scenario
• PORTER’S Five Forces
• PEST Analysis
4. Global Lifescience Reagent Market, By Product Type, 2016 – 2026, (US$ Million)
• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017 – 2026
• Segment Trends
• Biochemical Reagents
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Cell Culture Reagents
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Genomic Reagents
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Chromatography Reagents
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Flow Cytometry Reagents
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• PCR Reagents
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Electrophoresis Reagents
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Signal Transduction Reagents
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
5. Global Lifescience Reagent Market, By End User, 2016 – 2026, (US$ Million)
• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017 – 2026
• Segment Trends
• Diagnostics Laboratory
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Contract Research Manufacturers
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Academic and Research Institute
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
6. Global Lifescience Reagent Market, By Regions, 2016 – 2026, (US$ Million)
• Introduction
• Market Share Analysis, By Region, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, By Region, 2017 – 2026
• Regional Trends
• North America
• Market Size and Forecast, By  Product Type, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
• U.S.
• Canada
• Europe
• Market Size and Forecast, By  Product Type, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Market Size and Forecast, By  Product Type, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
• China
• Japan
• India
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Market Size and Forecast, By  Product Type, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Africa
• Market Size and Forecast, By  Product Type, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
• Northern Africa
• Central Africa
• South Africa
• Middle East
• Market Size and Forecast, By  Product Type, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
• GCC Countries
• Israel
• Rest of Middle East
7. Competitive Landscape
• Heat Map Analysis
• Company Profiles
• Analyst Views
8. Section
• References
• Research Methodology
• About us and Sales Contact

Other Exclusive Reports:

Flow Cytometry Market To Surpass US$ 9.3 Billion By 2027

Cell-Free Protein Expression Market To Surpass US$ 318.9 Million By 2027

Anti-Cathepsin B Market To Surpass US$ 208.19 Million By 2027

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837